The delay in diagnosing ALS means treatment and supportive care is received later, which can have a significant impact on ...
Troy Pruett, a Grapevine resident, will be competing in his 96th marathon this weekend and getting one step closer to the ...
In a rare move, the U.S. agency behind Medicare is warning Medicare Advantage providers they can’t have blanket policies that ...
Shelby Kinsey lives with a rare, fast-progressing form of ALS — but she has to spend her precious time fighting for insurance ...
The Centers for Medicare & Medicaid Services has directed private insurers providing Medicare Advantage plans to cover Biogen ...
It was seven months later when she was diagnosed with amyotrophic lateral sclerosis and bulbar palsy, both neurological ...
Zacks.com on MSN1d
CORT's Dazucorilant Fails to Meet Goal in Neurologic Disorder StudyCorcept Therapeutics Incorporated CORT announced data from the phase II DAZALS study evaluating its selective cortisol ...
People living with motor neuron disease (MND) will have more opportunities to participate in groundbreaking research, thanks ...
Growing up in rural areas, having younger parents, and having less education may all be environmental risk factors for ALS, ...
Corcept Therapeutics’ selective cortisol modulator failed to slow the progress of amyotrophic lateral sclerosis (ALS) in a ...
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe e ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback